GRMA is in the process of developing a Medical Device/Consumer Product (MD/CP) Standard. Our goal is to utilize a group of key industry stakeholders that represent the MD/CP sector to develop the standard over the remainder of 2019 and into the first quarter of 2020. Our strategy is to create a standard based on product risk that would encompass consumer goods, making the potential for true global acceptance. The GRMA will then adapt this standard into its array of audit schemes. This process is known as the “protocol method”. This [Read more]

Panel Discussion: CBD Product Standard Development: Alan Perlman (NSF) moderated a panel discussion of industry leaders at the GRMA Summit which centered around the complexities of the industry in relation to developing GMP Standards. Key discussion points included the need to connect GRMA with current GMP standard development activity by the industry. The question was raised as to the need to develop an entirely new standard or the potential to adopt the 455-2 Dietary Supplement Standard. Also discussed was the difficulty of working around the inclusion of hemp in the [Read more]